QualityStocksNewsBreaks – NurExone Biologic Inc. (TSX.V NRX) (OTCQB: NRXBF) to Highlight Exosome Technology, Pipeline and US Initiatives at NY Conference
Disseminated on behalf of NurExone Biologic Inc. (TSX.V NRX) (OTCQB:NRXBF) and may include paid advertising. NurExone Biologic (TSX.V NRX) (OTCQB:NRXBF) will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9-10 in New York City. Yoram Drucker, the company’s co-founder and chairman, is scheduled to present to investors and conduct one-on-one meetings. NurExone plans to use the event to showcase its exosome-based therapeutic platform, development pipeline, and U.S. manufacturing and commercialization initiatives as it advances preclinical programs and prepares for potential clinical development. To view the full press release, visit https://ibn.fm/o2PD0 To view…
